A Case Report of Laparotomic Myomectomy After The Use of Gnrh Analogue in A Brazilian Woman
DOI:
https://doi.org/10.14738/bjhmr.102.14485Keywords:
Uterine myomectomy, GnRH, myomaAbstract
Uterine leiomyoma is the most common genital benign tumor in the female population. It is estimated that about 20 to 40% of women will have leiomyoma during their reproductive stage. IBGE (Brazilian Institute of Geography and Statistics) estimated the Brazilian population to be over 200 million Brazilians, of which half are women and approximately 50% are of reproductive age; hence, by calculating the prevalence of leiomyomatosis, there would be just over 6 million women with symptomatic fibroids in Brazil that require clinical or surgical treatment.[1-3-4] Due to its presence during the reproductive period, it can be caused by infertility or recurrent spontaneous pregnancy loss. Hence, myomectomy can be necessary when the fibroid itself causes distortion of the endometrial cavity, or competes with the embryo for the same place, or when conservative treatment was ineffective. This report describes a case of myomectomy which was performed after treatment with goserelin acetate with considerable reduction of fibroids volume, probably facilitating surgical approach, decreasing the blood loss and the risk of hysterectomy conversion. In addition, other GnRH analogue benefits before surgery such as doctor’s impression of decrease in size and better mobility of the tumor and patients feeling of decrease of the abdominal volume and the bleeding. This subjective approach can optimize the timing of surgery and establish the number of injections.
References
CARSON, J.L. et al. Indications and hemoglobin thresholds for red blood cell transfusion in the adult. Uptodate, 2022.
FARRIS, M. et al. Uterine fibroids: an update on current and emerging medical treatment options. Ther Clin Risk Manag. 2019 Jan 23; 15:157-178. doi: 10.2147/TCRM.S147318. PMID: 30774352; PMCID: PMC6350833.
HAURANI, A. P. B. et al. Análise do tratamento com dose única do análogo do GnRH (acetato de gosserrelina - 10,8 mg) em pacientes com leiomiomatose uterina atendidas no Ambulatório de Ginecologia Endócrina de um Hospital Terciário de Curitiba. Arq Med Hosp Fac Cienc Med Santa Casa São Paulo. 2021; 66: e031.
ICHIGO, S. et al. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist. Arch Gynecol Obstet. 2011 Sep;284(3):667-70. doi: 10.1007/s00404-010-1732-6. Epub 2010 Oct 30. PMID: 21052701.
KONISHI, I. Diffuse Leiomyomatosis: Complete Myomectomy for Innumerable Small Nodules to Achieve Fertility Sparing and Childbearing. Surg J (N Y). 2019 Aug 29;6(Suppl 1): S50-S57. doi: 10.1055/s-0039-1693709. PMID: 32399490; PMCID: PMC7214083.
LEE, M. J. et al. Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist. Obstet Gynecol Sci. 2017 Jan;60(1):69-73. doi: 10.5468/ogs.2017.60.1.69. Epub 2017 Jan 19. PMID: 28217674; PMCID: PMC5313366.
LETHABY, A.; PUSCASIU, L.; VOLLENHOVEN, B. Preoperative medical therapy before surgery for uterine fibroids. Cochrane Database of Systematic Reviews 2017, Issue 11. Art. No.: CD000547. DOI: 10.1002/14651858.CD000547.pub2.
PARSANEZHAD, M. E. et al. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril. 2010 Jan;93(1):192-8. doi: 10.1016/j.fertnstert.2008.09.064. Epub 2009 Jan 9. PMID: 19135657.
SINAI, T. V. Medical therapy for fibroids: An overview. Best Pract Res Clin Obstet Gynaecol. 2018 Jan; 46:48-56. doi: 10.1016/j.bpobgyn.2017.09.007. Epub 2017 Sep 28. PMID: 29066045.
SOHN, G. S. et al. Working Group of Society of Uterine Leiomyoma. Current medical treatment of uterine fibroids. Obstet Gynecol Sci. 2018 Mar;61(2):192-201. doi: 10.5468/ogs.2018.61.2.192. Epub 2018 Feb 13. PMID: 29564309; PMCID: PMC5854898. 478
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sena-Martins, M., Tadini, V., Yamamoto, S. T., Mariani Neto, C., Kuroda, C. M., Santos, D. F., Moreira, J. M. S., Carnauba, L. A. B., Sousa, M. C., Novaczyk, M. B., Figueiredo, P. E. E.

This work is licensed under a Creative Commons Attribution 4.0 International License.